MedPath

EYLEA HD

EYLEA HD

Approved
DIN Number

02554798

Drug Class

Human

Market Date

Apr 7, 2025

Company
HC

Bayer Inc

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02554798
AIG Number0154950003
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription ,  Schedule D
A
ATC Code
S01LA05 AFLIBERCEPT
Product Specifications
Dosage FormSolution
Route of AdministrationIntravitreal
AHFS Classification52:92.00
Health Canada Classification

ACTIVE INGREDIENTS (1)

AFLIBERCEPTActive
Strength: 8 MG / 0.07 ML
Monograph: AFLIBERCEPT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.